PPARG Drives Molecular Networks as an Inhibitor for the Pathologic Development and Progression of Lung Adenocarcinoma
Previous studies showed that low PPARG expression was associated with poor prognosis of lung adenocarcinoma (LA) with limited mechanisms identified. We first conducted a large-scale literature-based data mining to identify potential molecular pathways where PPARG could exert influence on the patholo...
Saved in:
| Main Authors: | Min Zhao, Xiaoyang Li, Yunxiang Zhang, Hongming Zhu, Zhaoqing Han, Yan Kang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2020/6287468 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Genetics of PPARG and the Skeleton
by: Cheryl Ackert-Bicknell, et al.
Published: (2006-01-01) -
CDH3 promotes the progression of lung adenocarcinoma through driving epithelial-mesenchymal transition progress
by: Wenlin Gong, et al.
Published: (2025-08-01) -
Cadmium-associated molecular pathways drive gender-specific pathogenesis and prognosis in lung adenocarcinoma
by: Yusi Yang, et al.
Published: (2025-09-01) -
Gene mutation, clinical characteristics and pathology in resectable lung adenocarcinoma
by: Ji’an Zou, et al.
Published: (2025-01-01) -
Molecular subtyping of stage I lung adenocarcinoma via molecular alterations in pre-invasive lesion progression
by: Jun Shang, et al.
Published: (2025-03-01)